In the present study, the significant reduction in Akt, ERK, and p-38 phosphorylation in both cancer cell lines treated with haemathrin 2S, as opposed to the limited effect of WT haemathrin, suggests that haemathrin 2S effectively disrupts thrombin-induced signaling cascades. The gene discussed is MAPK14; the disease is cancer.